Literature DB >> 12355081

Top ten biotechnologies for improving health in developing countries.

Abdallah S Daar1, Halla Thorsteinsdóttir, Douglas K Martin, Alyna C Smith, Shauna Nast, Peter A Singer.   

Abstract

Most research into genomics and other related biotechnologies is concerned with the priorities of industrialized nations, and yet a limited number of projects have shown that these technologies could help improve health in developing countries. To encourage the successful application of biotechnology to global health, we carried out a study in which we asked an international group of eminent scientists with expertise in global health issues to identify the top ten biotechnologies for improving health in developing countries. The results offer concrete guidance to those in a position to influence the direction of research and development, and challenge common assumptions about the relevance and affordability of biotechnology for developing countries.

Mesh:

Substances:

Year:  2002        PMID: 12355081     DOI: 10.1038/ng1002-229

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  69 in total

1.  Setting global health research priorities.

Authors:  Ronald Labonte; Jerry Spiegel
Journal:  BMJ       Date:  2003-04-05

2.  Fabrication of a gel particle array in a microfluidic device for bioassays of protein and glucose in human urine samples.

Authors:  Ling Lin; Zhaoxin Gao; Huibin Wei; Haifang Li; Feng Wang; Jin-Ming Lin
Journal:  Biomicrofluidics       Date:  2011-08-08       Impact factor: 2.800

3.  Neglected diseases: under-funded research and inadequate health interventions. Can we change this reality?

Authors:  Carlos M Morel
Journal:  EMBO Rep       Date:  2003-06       Impact factor: 8.807

4.  Health research systems: promoting health equity or economic competitiveness?

Authors:  Bridget Pratt; Bebe Loff
Journal:  Bull World Health Organ       Date:  2011-12-07       Impact factor: 9.408

Review 5.  Health and economic benefits of an accelerated program of research to combat global infectious diseases.

Authors: 
Journal:  CMAJ       Date:  2004-11-09       Impact factor: 8.262

Review 6.  Risk mitigation of genetically modified bacteria and plants designed for bioremediation.

Authors:  John Davison
Journal:  J Ind Microbiol Biotechnol       Date:  2005-06-23       Impact factor: 3.346

Review 7.  Looking back, looking beyond: revisiting the ethics of genome generation.

Authors:  Minakshi Bharadwaj
Journal:  J Biosci       Date:  2006-03       Impact factor: 1.826

8.  Proteasome-independent major histocompatibility complex class I cross-presentation mediated by papaya mosaic virus-like particles leads to expansion of specific human T cells.

Authors:  Denis Leclerc; Diane Beauseigle; Jérome Denis; Hélène Morin; Christine Paré; Alain Lamarre; Réjean Lapointe
Journal:  J Virol       Date:  2006-11-22       Impact factor: 5.103

9.  Investigation of a fluorescence signal amplification mechanism used for the direct molecular detection of nucleic acids.

Authors:  Kim Doré; Mario Leclerc; Denis Boudreau
Journal:  J Fluoresc       Date:  2006-05-02       Impact factor: 2.217

10.  Patterned paper as a platform for inexpensive, low-volume, portable bioassays.

Authors:  Andres W Martinez; Scott T Phillips; Manish J Butte; George M Whitesides
Journal:  Angew Chem Int Ed Engl       Date:  2007       Impact factor: 15.336

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.